These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18026193)

  • 1. Endometrial carcinoma risk among women diagnosed with endometrial hyperplasia: the 34-year experience in a large health plan.
    Lacey JV; Ioffe OB; Ronnett BM; Rush BB; Richesson DA; Chatterjee N; Langholz B; Glass AG; Sherman ME
    Br J Cancer; 2008 Jan; 98(1):45-53. PubMed ID: 18026193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia.
    Lacey JV; Sherman ME; Rush BB; Ronnett BM; Ioffe OB; Duggan MA; Glass AG; Richesson DA; Chatterjee N; Langholz B
    J Clin Oncol; 2010 Feb; 28(5):788-92. PubMed ID: 20065186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies.
    Lacey JV; Mutter GL; Nucci MR; Ronnett BM; Ioffe OB; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
    Cancer; 2008 Oct; 113(8):2073-81. PubMed ID: 18720479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial hyperplasia and the risk of progression to carcinoma.
    Lacey JV; Chia VM
    Maturitas; 2009 May; 63(1):39-44. PubMed ID: 19285814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors of progression to endometrial cancer in women with endometrial hyperplasia: A retrospective cohort study.
    Jeong JY; Hwang SO; Lee B; Kim K; Kim YB; Park SH; Choi HY
    PLoS One; 2020; 15(12):e0243064. PubMed ID: 33259545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
    Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
    Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and clinical outcomes of endometrial hyperplasia during a 13-year period in Songklanagarind Hospital.
    Sirimusika N; Peeyananjarassri K; Suphasynth Y; Wootipoom V; Kanjanapradit K; Geater A
    J Med Assoc Thai; 2014 Mar; 97(3):260-6. PubMed ID: 25123004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of diagnosis of endometrial hyperplasia by curettage].
    Lü W; Xie X; Ye D
    Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(13):816-8. PubMed ID: 11798974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complexity of glandular architecture should be reconsidered in the classification and management of endometrial hyperplasia.
    Travaglino A; Raffone A; Saccone G; Mollo A; De Placido G; Mascolo M; Insabato L; Zullo F
    APMIS; 2019 Jun; 127(6):427-434. PubMed ID: 30802329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients.
    Kurman RJ; Kaminski PF; Norris HJ
    Cancer; 1985 Jul; 56(2):403-12. PubMed ID: 4005805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012-2020.
    Henderson I; Black N; Khattak H; ; Gupta JK; Rimmer MP
    PLoS Med; 2024 Feb; 21(2):e1004346. PubMed ID: 38421942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma.
    Lacey JV; Mutter GL; Ronnett BM; Ioffe OB; Duggan MA; Rush BB; Glass AG; Richesson DA; Chatterjee N; Langholz B; Sherman ME
    Cancer Res; 2008 Jul; 68(14):6014-20. PubMed ID: 18632658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial hyperplasia and progression to cancer: which classification system stratifies the risk better? A systematic review and meta-analysis.
    Raffone A; Travaglino A; Saccone G; Insabato L; Mollo A; De Placido G; Zullo F
    Arch Gynecol Obstet; 2019 May; 299(5):1233-1242. PubMed ID: 30810881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant risk of occult cancer in complex non-atypical endometrial hyperplasia.
    Travaglino A; Raffone A; Saccone G; D'Alessandro P; Arduino B; de Placido G; Mascolo M; Insabato L; Zullo F
    Arch Gynecol Obstet; 2019 Nov; 300(5):1147-1154. PubMed ID: 31531779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence rates of endometrial hyperplasia, endometrial cancer and hysterectomy from 1980 to 2003 within a large prepaid health plan.
    Lacey JV; Chia VM; Rush BB; Carreon DJ; Richesson DA; Ioffe OB; Ronnett BM; Chatterjee N; Langholz B; Sherman ME; Glass AG
    Int J Cancer; 2012 Oct; 131(8):1921-9. PubMed ID: 22290745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperplasia and carcinoma in secretory endometrium: a diagnostic challenge.
    Truskinovsky AM; Lifschitz-Mercer B; Czernobilsky B
    Int J Gynecol Pathol; 2014 Mar; 33(2):107-13. PubMed ID: 24487463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
    Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
    Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Hysteroscopic Risk Scoring System for Diagnosing Endometrial Hyperplasia and Adenocarcinoma.
    Ianieri MM; Staniscia T; Pontrelli G; Di Spiezio Sardo A; Manzi FS; Recchi M; Liberati M; Ceccaroni M
    J Minim Invasive Gynecol; 2016; 23(5):712-8. PubMed ID: 26940400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis.
    Doherty MT; Sanni OB; Coleman HG; Cardwell CR; McCluggage WG; Quinn D; Wylie J; McMenamin ÚC
    PLoS One; 2020; 15(4):e0232231. PubMed ID: 32343732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization.
    Li M; Song JL; Zhao Y; Wu SL; Liu HB; Tang R; Yan L
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):1022-1025. PubMed ID: 29119739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.